The Effect of Vitamin D Supplementation Post COVID-19 Infection and Related Outcomes: A Systematic Review and Meta-Analysis
Nutrients · 2024
DOI: 10.3390/nu16223794 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrients, 2024. Verfasst von Marina Sartini und 8 weiteren Autor:innen. Beteiligte Einrichtung: Operating Unit Hospital Hygiene, Galliera Hospital, 16128 Genoa, Italy. Hauptthemen laut MEDLINE: Vitamin D, Dietary Supplements, COVID-19, Length of Stay. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vitamin D’s role in COVID-19 management remains controversial. This meta-analysis aimed to evaluate the efficacy of vitamin D supplementation in patients with SARS-CoV-2 infection, focusing on mortality, intensive care unit (ICU) admissions, intubation rates, and hospital length of stay (LOS).
Methods
A systematic review of PubMed/MEDLINE, Scopus, Cochrane, and Google Scholar databases was conducted. Randomized controlled trials (RCTs) and analytical studies investigating vitamin D supplementation in COVID-19 patients were included. The meta-analysis was performed using STATA MP 18.5, employing random-effect or fixed-effect models based on heterogeneity.
Results
Twenty-nine studies (twenty-one RCTs, eight analytical) were analyzed. Vitamin D supplementation significantly reduced ICU admissions (OR = 0.55, 95% CI: 0.37 to 0.79) in RCTs and analytical studies (OR = 0.35, 95% CI: 0.18 to 0.66). Intubation rates were significantly reduced in RCTs (OR = 0.50, 95% CI: 0.27 to 0.92). Mortality reduction was significant in analytical studies (OR = 0.45, 95% CI: 0.24 to 0.86) but not in RCTs (OR = 0.80, 95% CI: 0.61 to 1.04). Subgroup analyses revealed more pronounced effects in older patients and severe COVID-19 cases. LOS showed a non-significant reduction (mean difference = −0.62 days, 95% CI: −1.41 to 0.18).
Conclusions
This meta-analysis suggests potential benefits of vitamin D supplementation in COVID-19 patients, particularly in reducing ICU admissions. However, the evidence varies across outcomes and patient subgroups. Discrepancies between RCTs and analytical studies highlight the need for further large-scale, well-designed trials accounting for baseline vitamin D status, standardized supplementation protocols, and patient characteristics to inform clinical guidelines for vitamin D use in COVID-19 management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Operating Unit Hospital Hygiene, Galliera Hospital, 16128 Genoa, Italy.
- Department of Health Sciences, University of Genoa, 16132 Genoa, Italy.
- Department of Infectious Diseases, Galliera Hospital, 16128 Genoa, Italy.
ORCID-Profile: Marina Sartini, Filippo Del Puente, Alessio Carbone, Elisa Schinca, Martino Oliva, Maria Luisa Cristina
Zitieren
APA
Sartini, M., Del Puente, F., Carbone, A., Schinca, E., Ottria, G., Dupont, C., Piccinini, C., Oliva, M., & Cristina, M. L. (2024). The Effect of Vitamin D Supplementation Post COVID-19 Infection and Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients. https://doi.org/10.3390/nu16223794
Vancouver
Sartini M, Del Puente F, Carbone A, Schinca E, Ottria G, Dupont C, et al. The Effect of Vitamin D Supplementation Post COVID-19 Infection and Related Outcomes: A Systematic Review and Meta-Analysis. Nutrients. 2024. doi:10.3390/nu16223794
BibTeX
@article{Sartini2024,
author = {Sartini, Marina and Del Puente, Filippo and Carbone, Alessio and Schinca, Elisa and Ottria, Gianluca and Dupont, Chiara and Piccinini, Carolina and Oliva, Martino and Cristina, Maria Luisa},
title = {The Effect of Vitamin D Supplementation Post COVID-19 Infection and Related Outcomes: A Systematic Review and Meta-Analysis},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16223794}
}
EUVIMED